Pancreatic Cancer Research

ResearcherTokyo Metropolitan Komagome HospitalNo recent work listed

Sara Hayakawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110940953. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. The outcome of a multidisciplinary approach incorporating neoadjuvant chemoradiotherapy with S1 for resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ags3.12624↗
  2. Safety of biliary stent placement followed by definitive chemoradiotherapy in patients with pancreatic cancer with bile duct obstruction. Co-author DOI 10.21037/jgo-21-198↗
  3. [Multidisciplinary Treatment Aids Long-Term Stage Ⅳ Pancreatic Cancer Survival-A Case Report]. Co-author PMID 33468777↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaru Matsumura · 2 shared papers, 2020–2023 · strength 0.30
  2. Yasuji Seyama · 2 shared papers, 2020–2023 · strength 0.30
  3. Yusuke Ome · 1 shared paper, 2023 · strength 0.18
  4. Goro Honda · 1 shared paper, 2023 · strength 0.18
  5. Masataka Kikuyama · 1 shared paper, 2023 · strength 0.18
  6. Kei Ito · 1 shared paper, 2021 · strength 0.17
  7. Katsuyuki Karasawa · 1 shared paper, 2021 · strength 0.17
  8. Shinya Sakamoto · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.